Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines Guidelines
| Authors: | Ettinger, D. S.; Wood, D. E.; Aggarwal, C.; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Bruno, D. S.; Chang, J. Y.; Chirieac, L. R.; D'Amico, T. A.; Dilling, T. J.; Dobelbower, M.; Gettinger, S.; Govindan, R.; Gubens, M. A.; Hennon, M.; Horn, L.; Lackner, R. P.; Lanuti, M.; Leal, T. A.; Lin, J.; Loo, B. W. Jr; Martins, R. G.; Otterson, G. A.; Patel, S. P.; Reckamp, K. L.; Riely, G. J.; Schild, S. E.; Shapiro, T. A.; Stevenson, J.; Swanson, S. J.; Tauer, K. W.; Yang, S. C.; Gregory, K.; Hughes, M. |
| Title: | Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines |
| Abstract: | The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances". © 2019 JNCCN - Journal of the National Comprehensive Cancer Network. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 17 |
| Issue: | 12 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2019-12-01 |
| Start Page: | 1464 |
| End Page: | 1472 |
| Language: | English |
| DOI: | 10.6004/jnccn.2019.0059 |
| PROVIDER: | scopus |
| PUBMED: | 31805526 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
